


AKIGAI
Biotechnology Research • Oslo, Oslo, Norway • 1-10 Employees
Company overview
| Headquarters | Oslo, Oslo, Norway |
| Website | |
| NAICS | 541714 |
| Keywords | Biotech, Drug Development, Neuropathic Pain, Egfr Inhibitors |
| Founded | 2023 |
| Employees | 1-10 |
Key Contacts at AKIGAI
Christian Kersten
Founder And Ceo
Marte Cameron
Founder And Cmo
AKIGAI Email Formats
AKIGAI uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@akigai.no), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@akigai.no | 66.7% |
{first initial}.{last name} | j.doe@akigai.no | 33.3% |
About AKIGAI
We have an obligation. Because we have witnessed the effects again and again. Like many breakthrough discoveries in medicine, the understanding that relief of neuropathic pain was a result of EGFR inhibition came serendipitously.
AKIGAI revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
AKIGAI has 3 employees across 2 departments.
Departments
Number of employees
Funding Data
AKIGAI has never raised funding before.
AKIGAI Tech Stack
Discover the technologies and tools that power AKIGAI's digital infrastructure, from frameworks to analytics platforms.
CDN
Font scripts
Video players
CDN
JavaScript libraries
Miscellaneous
Security
Miscellaneous
Video players
Page builders
CDN
Font scripts
Frequently asked questions
4.8
40,000 users



